Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2022

Tumour-agnostic precision therapeutics: What is the way forward? (In collaboration with National Societies)

Tumour-agnostic therapies: Considerations on generation of evidence frameworks

Date

01 Dec 2022

Session

Tumour-agnostic precision therapeutics: What is the way forward? (In collaboration with National Societies)

Topics

Targeted Therapy;  Molecular Oncology;  Cancer Diagnostics

Tumour Site

Presenters

Christoph Benedikt Westphalen

Authors

C.B. Westphalen

Author affiliations

  • Medical Oncology Department, LMU Klinikum der Universität München, 81377 - Munich/DE

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.